5 Best-Performing S&P 500 Stocks in the Last 10 Years
DexCom, Inc. (NASDAQ:DXCM) was incorporated in 1999 and is headquartered in San Diego, California.
Dexcom Inc (DXCM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 3,070,874 | $228,872 | +881% | 0.05% |
| 2. | 97,404,000 | $180,004 | 0.21% | ||
| 3. | 83,469,000 | $154,000 | -1% | 6.14% | |
| 4. | 81,293,000 | $149,881 | +20% | 1.13% | |
| 5. | Holocene Advisors Brandon Haley | 1,883,466 | $140,375 | +343% | 0.84% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $50.01 | 25,000 | Director | 58,502 | 2017-11-07 | Filing | |
| $49.61 | 10,000 | Director | 33,502 | 2017-11-06 | Filing | |
| $15.50 | 70,000 | Director | 121,975 | 2013-03-11 | Filing | |
| $10.37 | 1,000 | Director | 6,000 | 2012-03-08 | Filing | |
| $10.34 | 1,000 | Director | 5,000 | 2012-03-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $81.63 | 5 | Officer | 26,536 | 2022-09-01 | Filing | |
| $84.21 | 1,000 | Officer | 137,700 | 2022-08-23 | Filing | |
| $83.07 | 1,000 | Officer | 138,700 | 2022-07-25 | Filing | |
| $72.55 | 1,000 | Officer | 139,700 | 2022-06-23 | Filing | |
| $301.57 | 600 | Officer | 17,408 | 2022-06-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 4,074,786 | $303,693,801 | 0.15% | |
| 2. | 498,311 | $37,139,119 | 0.05% | |
| 3. | 200,226 | $14,922,843 | 0.13% | |
| 4. | 911 | $6,789,683 | 0.01% | |
| 5. | 73,900 | $5,507,767 | 0.05% |
News See All
Here's Why Baron Funds Remain Excited in DexCom (DXCM)
Baron Funds, an asset management firm, published its “Baron Small Cap Fund” second quarter 2022 investor letter – a copy of which can be downloaded here.
Is it Still Worthy to Invest in DexCom (DXCM)?
ClearBridge Investments, an investment management firm, published its “Large Cap Growth ESG Strategy” second quarter 2022 investor letter – a copy of which can be downloaded here.
10 Best Healthcare Stocks To Buy Now According To Motley Fool’s 1623 Capital
In this article, we talk about the 10 best healthcare stocks to buy now according to Motley Fool's 1623 Capital.
11 Companies Making Headlines Following Earnings Reports
In this article, we will take a look at the 11 companies making headlines following earnings reports.
Is DexCom (DXCM) a Smart Long-Term Buy?
ClearBridge Investments, an investment management firm, published its “Large Cap Growth Strategy” first quarter 2021 investor letter – a copy of which can be downloaded here.
Why These 10 Stocks Are Trending on Monday
Amidst the uncertainty over the Russia-Ukraine conflict and reports of rising Covid-19 cases in China, it's a mixed day on Wall Street.
How Did Hedge Funds' DexCom, Inc. (DXCM) Bets Fare?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
10 Jim Cramer Stocks to Buy in Q1 2022
Investors have been scrambling to identify the “real value” of stocks as reports suggest that as many as four interest rate hikes by the Federal Reserve are on the horizon for 2022.
Hedge Funds Are Crazy About DexCom, Inc. (DXCM)
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth ...
Billionaire Hedge Funds
